Skip to main content
. 2020 Feb 26;2020:4869467. doi: 10.1155/2020/4869467

Table 1.

Hormonal evaluation.

Initial screening Jul 2013 Repeat screening Nov 2018 Jan 2019 Jun 2019 (1 month postoperative)
AM cortisol with 1 mg overnight DST 1.2 mcg/dL 7.3 mcg/dL 11.4 mcg/dL 0.4 mcg/dL

Late-night salivary cortisol at 0300 (0–0.090 mcg/dL) 0.175 mcg/dL, 0.173 mcg/dL, 0.097 mcg/dL

24 hr urinary cortisol (36–137 mcg/24 hr) 89.0 mcg/24 hr

Adrenocorticotrophic hormone (ACTH) (6.00–50 pg/mL) 45.62 pg/mL

24 hr urinary metanephrines (74–297 mcg/24 hr) 505 mcg/24 hr 864 mcg/24 hr

24 hr urinary normetanephrine (105–354 mcg/24 hr) 434 mcg/24 hr 690 mcg/24 hr

24 hr urinary metanephrines, total (179–651 mcg/24 hr) 939 mcg/24 hr 1554 mcg/24 hr

Plasma-free metanephrine (0–62 pg/mL) 403 pg/mL 199 pg/mL 35 pg/mL

Plasma-free normetanephrine (0–145 pg/mL) 482 pg/mL 176 pg/mL 189 pg/mL

Plasma renin (0.25–5.82 ng/mL/h) 1.77 ng/mL/h 1.121 ng/mL/h

Plasma aldosterone (0–30 ng/dL) 13 ng/dL 10.6 ng/dL